LifeMD delays Q3 earnings, expects late 10-Q filing due to $4.6M revenue recognition corrections

LifeMD, Inc.

Q3 2025 earnings rescheduled to Nov 17, 2025; expects to file Form 12b-25 for late 10-Q.
Rev rec errors for periods ended Dec 31, 2023, Dec 31, 2024, and Jun 30, 2025; cumulative $4.6M (1.4% of cumulative revenue).
Adjustments do not materially impact reported revenue vs. guidance; no effect on cash flow or cash position.
Company's auditors have not completed review; adjustments may change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.